Publication details
Sledování nákladné pneumoonkologické léčby pokročilého nemalobuněčného karcinomu plic v první linii v registru TULUNG v České republice (stav k 15.3.2017)
Title in English | Follow-up of costly pneumooncological treatment of advanced NSCLC with first-line treatment according to the TULUNG registry in the Czech Republic (up to March 15, 2017) |
---|---|
Authors | |
Year of publication | 2017 |
Type | Popularization text |
MU Faculty or unit | |
Citation | |
Description | Five drugs (pemetrexed,erlotinib, bevacizumab, gefinitib and afatinib) were used as first-line treatment of non-small cell lung cancer (NSCLC) in 2234 patients in the Czech Republic between 2006 and 2017. A detailed morphological and genetic analysis of NSCLC was available. The outcomes of treatment are analysed. |